Sunday, May 3, 2026

Exploring US patient and caregiver perspectives on burden associated with Friedreich Ataxia

›
Lawson, R., Natarajan, S., Correll, J.R. et al. Exploring US patient and caregiver perspectives on burden associated with Friedreich Ataxia....

PO-04-187 OVERACTIVITY OF MONOAMINE OXIDASE A IN A MOUSE MODEL OF FRIEDREICH’S ATAXIA CONTRIBUTES TO CATECHOLAMINERGIC ARRHYTHMIAS AND OXIDATIVE STRESS

›
Figueroa F, Bahriz S, Sellers R ... PO-04-187 OVERACTIVITY OF MONOAMINE OXIDASE A IN A MOUSE MODEL OF FRIEDREICH’S ATAXIA CONTRIBUTES TO CAT...

Dimethyl Fumarate Normalizes Expression of Friedreich Ataxia Gene

›
Neurology Today - American Academy of Neurology; APRIL 20, 2026,  Dan Hurley.  Dr. Gramaglia said some patients already on omaveloxolone mig...

Efficacy and Safety of Dimethyl Fumarate in Friedreich Ataxia: Primary Results From the Phase Two, Randomized, Double-blind, Placebo-controlled DMF-FA-201 Trial

›
S26 - Movement Disorders: Clinical Trials and Therapeutics. American Academy of Neurology. Francesco Sacca et al.  DMF significantly increas...

Clinical Challenges in Managing Diabetes Mellitus in Friedreich’s Ataxia

›
Clinical Challenges in Managing Diabetes Mellitus in Friedreich’s Ataxia. Aarya Naik, Hooman Oktaei, Endocrine Practice , 32, S66-S67.   Doi...

Beyond the Diagnosis of Friedreich’s Ataxia: International Cultural Factors in Patient Decisions

›
Lauren Mitchell, Cara Stricklin, Nikola Dragojlovic, Beyond the Diagnosis of Friedreich’s Ataxia: International Cultural Factors in Patient ...

TLR4-mediated neuroimmune signalling drives proprioceptive neuron degeneration in Friedreich ataxia

›
TLR4-mediated neuroimmune signalling drives proprioceptive neuron degeneration in Friedreich ataxia, Deepika Mokkachamy Chellapandi, Peio An...
Tuesday, April 28, 2026

Multimodal MRI and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia

›
Multimodal MRI and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia. Susmita Saha, Nellie Georgiou-Karistianis,...
Monday, April 27, 2026

The TRKB Agonist 7,8-dihydroxyflavone Alleviates DNA Damage and Apoptosis in a Neuronal Cell Model of Friedreich’s Ataxia

›
Galán-Cruz, J., Vicente-Acosta, A., Loría, F. et al. The TRKB Agonist 7,8-dihydroxyflavone Alleviates DNA Damage and Apoptosis in a Neuronal...

Novel Precision Gene Therapy for Friedreich’s Ataxia with Dr. Gabriel Brooks Solid Biosciences

›
Apr 23, 2026 .  Solid Biosciences  Dr. Gabriel Brooks is Chief Medical Officer at Solid Biosciences, a precision molecular genetic medicines...